Clinical Trial Update: mAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria [NA]

View source ↗

Summary

A clinical trial update indicates ongoing recruitment in Nigeria for a study evaluating increased adoption of hydroxyurea to manage sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: New York University | Conditions: Sickle Cell Disease | NA | Status: RECRUITING